Literature DB >> 24026096

Evidence for a tumor suppressor role for the large tumor suppressor genes LATS1 and LATS2 in human cancer.

Tian Yu1, John Bachman, Zhi-Chun Lai.   

Abstract

The role of Large tumor suppressor LATS/Warts in human cancer is not clearly understood. Here we show that hLATS1/2 cancer mutations affect their expression and kinase activity. hLATS1/2 mutants exhibit a decreased activity in inhibiting YAP and tissue growth. Therefore, hLATS1/2 alleles from human cancer can be loss-of-function mutations.

Entities:  

Keywords:  Hippo signaling; LATS1; LATS2; human cancer; protein kinase

Mesh:

Substances:

Year:  2013        PMID: 24026096      PMCID: PMC3813850          DOI: 10.1534/genetics.113.156372

Source DB:  PubMed          Journal:  Genetics        ISSN: 0016-6731            Impact factor:   4.562


  11 in total

1.  TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway.

Authors:  Qun-Ying Lei; Heng Zhang; Bin Zhao; Zheng-Yu Zha; Feng Bai; Xin-Hai Pei; Shimin Zhao; Yue Xiong; Kun-Liang Guan
Journal:  Mol Cell Biol       Date:  2008-01-28       Impact factor: 4.272

Review 2.  The Hippo pathway: regulators and regulations.

Authors:  Fa-Xing Yu; Kun-Liang Guan
Journal:  Genes Dev       Date:  2013-02-15       Impact factor: 11.361

3.  Mice deficient of Lats1 develop soft-tissue sarcomas, ovarian tumours and pituitary dysfunction.

Authors:  M A St John; W Tao; X Fei; R Fukumoto; M L Carcangiu; D G Brownstein; A F Parlow; J McGrath; T Xu
Journal:  Nat Genet       Date:  1999-02       Impact factor: 38.330

4.  Human homologue of the Drosophila melanogaster lats tumour suppressor modulates CDC2 activity.

Authors:  W Tao; S Zhang; G S Turenchalk; R A Stewart; M A St John; W Chen; T Xu
Journal:  Nat Genet       Date:  1999-02       Impact factor: 38.330

5.  Tumor suppressor LATS1 is a negative regulator of oncogene YAP.

Authors:  Yawei Hao; Alex Chun; Kevin Cheung; Babak Rashidi; Xiaolong Yang
Journal:  J Biol Chem       Date:  2007-12-24       Impact factor: 5.157

6.  The Drosophila tumor suppressor gene warts encodes a homolog of human myotonic dystrophy kinase and is required for the control of cell shape and proliferation.

Authors:  R W Justice; O Zilian; D F Woods; M Noll; P J Bryant
Journal:  Genes Dev       Date:  1995-03-01       Impact factor: 11.361

7.  Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control.

Authors:  Bin Zhao; Xiaomu Wei; Weiquan Li; Ryan S Udan; Qian Yang; Joungmok Kim; Joe Xie; Tsuneo Ikenoue; Jindan Yu; Li Li; Pan Zheng; Keqiang Ye; Arul Chinnaiyan; Georg Halder; Zhi-Chun Lai; Kun-Liang Guan
Journal:  Genes Dev       Date:  2007-11-01       Impact factor: 11.361

8.  An optimized transgenesis system for Drosophila using germ-line-specific phiC31 integrases.

Authors:  Johannes Bischof; Robert K Maeda; Monika Hediger; François Karch; Konrad Basler
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-22       Impact factor: 11.205

Review 9.  The Hippo pathway and human cancer.

Authors:  Kieran F Harvey; Xiaomeng Zhang; David M Thomas
Journal:  Nat Rev Cancer       Date:  2013-03-07       Impact factor: 60.716

10.  Identifying tumor suppressors in genetic mosaics: the Drosophila lats gene encodes a putative protein kinase.

Authors:  T Xu; W Wang; S Zhang; R A Stewart; W Yu
Journal:  Development       Date:  1995-04       Impact factor: 6.868

View more
  20 in total

1.  Expression of LATS1 contributes to good prognosis and can negatively regulate YAP oncoprotein in non-small-cell lung cancer.

Authors:  Xu-Yong Lin; Xiu-Peng Zhang; Jun-Hua Wu; Xue-Shan Qiu; En-Hua Wang
Journal:  Tumour Biol       Date:  2014-03-29

2.  LATS2 promoter hypermethylation and its effect on gene expression in human breast cancer.

Authors:  Saki Matsui; Naofumi Kagara; Chieko Mishima; Yasuto Naoi; Masafumi Shimoda; Atsushi Shimomura; Kenzo Shimazu; Seung Jin Kim; Shinzaburo Noguchi
Journal:  Oncol Lett       Date:  2017-12-06       Impact factor: 2.967

3.  YAP1 Regulates OCT4 Activity and SOX2 Expression to Facilitate Self-Renewal and Vascular Mimicry of Stem-Like Cells.

Authors:  Namrata Bora-Singhal; Jonathan Nguyen; Courtney Schaal; Deepak Perumal; Sandeep Singh; Domenico Coppola; Srikumar Chellappan
Journal:  Stem Cells       Date:  2015-06       Impact factor: 6.277

4.  MicroRNA-135b regulates apoptosis and chemoresistance in colorectal cancer by targeting large tumor suppressor kinase 2.

Authors:  Yuqi He; Jianxun Wang; Jiheng Wang; Victoria Yee-Wa Yung; Emily Hsu; Aiqin Li; Qian Kang; Junbiao Ma; Qingfeng Han; Peng Jin; Rui Xing; Youyong Lu; Jianqiu Sheng
Journal:  Am J Cancer Res       Date:  2015-03-15       Impact factor: 6.166

5.  LATS2 Inhibits Malignant Behaviors of Glioma Cells via Inactivating YAP.

Authors:  Yi Shi; Decheng Geng; Yu Zhang; Min Zhao; Yan Wang; Yang Jiang; Rutong Yu; Xiuping Zhou
Journal:  J Mol Neurosci       Date:  2019-02-15       Impact factor: 3.444

6.  Large tumor suppressor 2, LATS2, activates JNK in a kinase-independent mechanism through ASK1.

Authors:  Lauren Rusnak; Cong Tang; Qi Qi; Xiulei Mo; Haian Fu
Journal:  J Mol Cell Biol       Date:  2018-12-01       Impact factor: 6.216

7.  The clinical significance and biological function of large tumour suppressor 2 in hepatocellular carcinoma.

Authors:  Rong Liang; Yan Lin; Chun-Ling Yuan; Zhi-Hui Liu; Yong-Qiang Li; Xiao-Ling Luo; Jia-Zhou Ye; Hai-Hong Ye
Journal:  Cell Prolif       Date:  2017-03-01       Impact factor: 6.831

8.  Molecular Alterations and Expression Dynamics of LATS1 and LATS2 Genes in Non-Small-Cell Lung Carcinoma.

Authors:  Showkat A Malik; Mosin S Khan; Majeed Dar; Mahboob Ul Hussain; Mohammad A Shah; Sheikh M Shafi; Syed Mudassar
Journal:  Pathol Oncol Res       Date:  2017-04-22       Impact factor: 3.201

Review 9.  Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer.

Authors:  Fa-Xing Yu; Bin Zhao; Kun-Liang Guan
Journal:  Cell       Date:  2015-11-05       Impact factor: 41.582

10.  MiR-25 promotes ovarian cancer proliferation and motility by targeting LATS2.

Authors:  Shujun Feng; Wenjing Pan; Ye Jin; Jianhua Zheng
Journal:  Tumour Biol       Date:  2014-09-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.